This conference will connect scientists and researchers to share perspectives on the latest topics in drug discovery for neurodegenerative diseases, such as rare CNS disorders, translational biomarkers, wearable devices and other technologies, and more.  The meeting will provide a forum at which to discuss issues such as: What are the best models of private/public partnerships? How are patient advocacy groups changing the way we think about funding and research? How will we work with government groups?